These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3013264)

  • 1. Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure.
    Funck-Brentano C; Chatellier G; Alexandre JM
    Br Heart J; 1986 Jun; 55(6):596-8. PubMed ID: 3013264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure.
    Stewart JT; Lovett D; Joy M
    Br Heart J; 1986 Nov; 56(5):489-90. PubMed ID: 3024687
    [No Abstract]   [Full Text] [Related]  

  • 3. Enalapril Associated with Furosemide Induced Acute Kidney Injury in an Infant with Heart Failure. A Case Report, a Revision of the Literature and a Pharmacovigilance Database Analysis.
    Fabiano V; Carnovale C; Gentili M; Radice S; Zuccotti GV; Clementi E; Perrotta C; Mameli C
    Pharmacology; 2016; 97(1-2):38-42. PubMed ID: 26575260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.
    Cleland JG; Gillen G; Dargie HJ
    Eur Heart J; 1988 Feb; 9(2):132-41. PubMed ID: 2832173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the safety and efficacy of telmisartan and enalapril, with the potential addition of frusemide, in moderate-renal failure patients with mild-to-moderate hypertension.
    Hannedouche T; Chanard J; Baumelou B;
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):246-54. PubMed ID: 11881131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life-threatening hyperkalaemia in an elderly patient receiving captopril, furosemide (frusemide) and potassium supplements.
    Chan TY; Critchley JA
    Drug Saf; 1992; 7(2):159-61. PubMed ID: 1605901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia.
    Adigun AQ; Ajayi AA
    Eur J Heart Fail; 2001 Jun; 3(3):359-63. PubMed ID: 11378008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications during enalapril and diuretic therapy for congestive cardiac failure.
    Mehta S; Vijayakumar M
    Indian J Pediatr; 2009 Sep; 76(9):963-4. PubMed ID: 19904515
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal toxicity of enalapril in very elderly patients with progressive, severe congestive heart failure.
    Schwartz D; Averbuch M; Pines A; Kornowski R; Levo Y
    Chest; 1991 Dec; 100(6):1558-61. PubMed ID: 1959395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congestive heart failure and converting enzyme inhibition: failure of current prognostic criteria for predicting subsequent renal insufficiency.
    Odum J; Carson P; Russell G
    Postgrad Med J; 1991 Apr; 67(786):354-7. PubMed ID: 2068028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute reversible kidney insufficiency due to enalapril during diuretic-treated heart insufficiency].
    Degenhardt S
    Dtsch Med Wochenschr; 1987 Jun; 112(24):960-3. PubMed ID: 3036457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure.
    Packer M; Lee WH; Kessler PD; Medina N; Yushak M; Gottlieb SS
    J Am Coll Cardiol; 1987 Oct; 10(4):837-44. PubMed ID: 2821091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management.
    Packer M; Kessler PD; Gottlieb SS
    Postgrad Med J; 1986; 62 Suppl 1():179-82. PubMed ID: 3022272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.
    Cleland JG; Dargie HJ; Ball SG; Gillen G; Hodsman GP; Morton JJ; East BW; Robertson I; Ford I; Robertson JI
    Br Heart J; 1985 Sep; 54(3):305-12. PubMed ID: 2994698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure.
    Packer M; Lee WH; Medina N; Yushak M; Kessler PD
    Ann Intern Med; 1987 Mar; 106(3):346-54. PubMed ID: 3028221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalapril-induced acute renal failure in a newborn infant.
    Dutta S; Narang A
    Pediatr Nephrol; 2003 Jun; 18(6):570-2. PubMed ID: 12698328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of oxidative stress augments natriuretic effect of furosemide in moderate heart failure.
    Tomiyama H; Watanabe G; Yoshida H; Doba N; Yamashina A
    Am Heart J; 2003 Jan; 145(1):E2. PubMed ID: 12514674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.